Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment DOI Creative Commons

Xinfu Zou,

Guoqiang Zou,

Xinyan Zou

et al.

PeerJ, Journal Year: 2024, Volume and Issue: 12, P. e17061 - e17061

Published: March 13, 2024

Introduction An increasing number of studies have demonstrated that altered microbial diversity and function (such as metabolites), or ecological disorders, regulate bowel–brain axis involvement in the pathophysiologic processes Alzheimer’s disease (AD). The dysregulation microbes their metabolites can be a double-edged sword AD, presenting possibility microbiome-based treatment options. This review describes link between imbalances interactions AD modalities microbiota, potential interventions such prebiotics, probiotics, synbiotics, fecal microbiota transplantation, dietary complementary therapeutic strategies targeting pathogenesis progression. Survey methodology Articles from PubMed china.com on intestinal flora were summarized to analyze data conclusions carefully ensure comprehensiveness, completeness, accuracy this review. Conclusions Regulating gut balance upregulates neurotrophic factor expression, regulates microbiota-gut-brain (MGB) axis, suppresses inflammatory responses. Based emerging research, explored novel directions for future research clinical interventions, injecting new vitality into development.

Language: Английский

Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis DOI Creative Commons
Antonio Di Sabatino, Giovanni Santacroce, Carlo Maria Rossi

et al.

Internal and Emergency Medicine, Journal Year: 2023, Volume and Issue: 18(6), P. 1635 - 1646

Published: July 4, 2023

The intestinal mucosa represents the most extensive human barrier having a defense function against microbial and food antigens. This is represented externally by mucus layer, consisting mainly of mucins, antimicrobial peptides, secretory immunoglobulin A (sIgA), which serves as first interaction with microbiota. Below placed epithelial monolayer, comprising enterocytes specialized cells, such goblet Paneth enterochromaffin others, each specific protective, endocrine, or immune function. layer interacts both luminal environment underlying lamina propria, where mucosal immunity processes primarily take place. Specifically, between microbiota an intact results in activation tolerogenic processes, mediated FOXP3+ regulatory T homeostasis. Conversely, impairment function, alteration normal composition (dysbiosis), imbalance pro- anti-inflammatory factors may result inflammation disease. Another crucial component gut-vascular barrier, formed endothelial pericytes, glial regulates passage molecules into bloodstream. aim this review to examine various components assessing their system, focus on immunological homeostasis inflammation.

Language: Английский

Citations

37

Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence DOI Creative Commons
Xiaoyan Liu, Yi Liu, Junlin Liu

et al.

Neural Regeneration Research, Journal Year: 2023, Volume and Issue: 19(4), P. 833 - 845

Published: Aug. 14, 2023

A growing body of evidence suggests that the gut microbiota contributes to development neurodegenerative diseases via microbiota-gut-brain axis. As a contributing factor, dysbiosis always occurs in pathological changes diseases, such as Alzheimer's disease, Parkinson's and amyotrophic lateral sclerosis. High-throughput sequencing technology has helped reveal bidirectional communication between central nervous system enteric is facilitated by microbiota's diverse microorganisms, for both neuroimmune neuroendocrine systems. Here, we summarize bioinformatics analysis wet-biology validation metagenomics with an emphasis on multi-omics studies virome. The pathogen-associated signaling biomarkers identifying brain disorders potential therapeutic targets are also elucidated. Finally, discuss role diet, prebiotics, probiotics, postbiotics exercise interventions remodeling microbiome reducing symptoms diseases.

Language: Английский

Citations

29

Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s disease DOI
Sonal Dubey, Ekta Singh

Inflammopharmacology, Journal Year: 2023, Volume and Issue: 31(2), P. 717 - 730

Published: March 18, 2023

Language: Английский

Citations

25

Gut commensals and their metabolites in health and disease DOI Creative Commons
Hari Krishnan Krishnamurthy, Michelle Pereira,

Jophi Bosco

et al.

Frontiers in Microbiology, Journal Year: 2023, Volume and Issue: 14

Published: Nov. 8, 2023

Purpose of review This comprehensively discusses the role gut microbiome and its metabolites in health disease sheds light on importance a holistic approach assessing gut. Recent findings The consisting bacteriome, mycobiome, archaeome, virome has profound effect human health. Gut dysbiosis which is characterized by perturbations microbial population not only results gastrointestinal (GI) symptoms or conditions but can also give rise to extra-GI manifestations. microorganisms produce (short-chain fatty acids, trimethylamine, hydrogen sulfide, methane, so on) that are important for several interkingdom interactions functions. They participate various host metabolic processes. An alteration species affect their respective metabolite concentrations have serious implications. Effective assessment crucial as it provide insights into one’s overall Summary Emerging evidence highlights disease. As implicated GI well symptoms, plays well-being host. may status leading more care.

Language: Английский

Citations

24

Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment DOI Creative Commons

Xinfu Zou,

Guoqiang Zou,

Xinyan Zou

et al.

PeerJ, Journal Year: 2024, Volume and Issue: 12, P. e17061 - e17061

Published: March 13, 2024

Introduction An increasing number of studies have demonstrated that altered microbial diversity and function (such as metabolites), or ecological disorders, regulate bowel–brain axis involvement in the pathophysiologic processes Alzheimer’s disease (AD). The dysregulation microbes their metabolites can be a double-edged sword AD, presenting possibility microbiome-based treatment options. This review describes link between imbalances interactions AD modalities microbiota, potential interventions such prebiotics, probiotics, synbiotics, fecal microbiota transplantation, dietary complementary therapeutic strategies targeting pathogenesis progression. Survey methodology Articles from PubMed china.com on intestinal flora were summarized to analyze data conclusions carefully ensure comprehensiveness, completeness, accuracy this review. Conclusions Regulating gut balance upregulates neurotrophic factor expression, regulates microbiota-gut-brain (MGB) axis, suppresses inflammatory responses. Based emerging research, explored novel directions for future research clinical interventions, injecting new vitality into development.

Language: Английский

Citations

11